Brown Regina 4
4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Oct 29, 2024
Insider Transaction Report
Form 4
Brown Regina
Director
Transactions
- Award
Options to Purchase Common Stock
2024-09-30+6,269→ 6,269 totalExercise: $1.30From: 2024-09-30Exp: 2029-09-30→ Common (6,269 underlying)
Holdings
- 10,000
Options to Purchase Common Stock
Exercise: $2.37From: 2024-06-30Exp: 2029-06-30→ Common (10,000 underlying) - 10,000
Options to Purchase Common Stock
Exercise: $30.30From: 2021-06-30Exp: 2026-06-30→ Common (10,000 underlying) - 4,904
Options to Purchase Common Stock
Exercise: $2.37From: 2024-06-30Exp: 2029-06-30→ Common (4,904 underlying) - 10,000
Options to Purchase Common Stock
Exercise: $7.45From: 2022-06-30Exp: 2027-06-30→ Common (10,000 underlying) - 25,000
Options to Purchase Common Stock
Exercise: $28.00From: 2021-05-11Exp: 2026-05-11→ Common (25,000 underlying) - 10,000
Options to Purchase Common Stock
Exercise: $5.88From: 2023-06-30Exp: 2028-06-30→ Common (10,000 underlying)
Footnotes (1)
- [F1]Effective September 30, 2024, the reporting person was granted stock options to purchase an aggregate of 6,296 shares vesting immediately. The grant was in lieu of the quarterly cash compensation due to the reporting person under the Board Compensation Plan.